Hikma Pharmaceuticals USA INC. recalls Abirtega (abiraterone acetate) USP
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.
- Products
-
- Abirtega (abiraterone acetate) USP
- Where it was sold
-
Nationwide within the United States
Nationwide
- Units affected
- 2136 bottles
- About this recall
- Abirtega (abiraterone acetate) USP, 250 mg, 120-count bottles, Rx only, Rx only, Mfd for: Hikma Pharmaceuticals USA Inc., Berkley Heights, NJ 07922 USA by: Arab Pharmaceuticals Manufacturing PSC PO Box 41, Sahab-Jordon, NDC 82249-011-12.